1gw, you're wasting your time, he's an absolute plank, just filter him like everyone else does! |
Something brewing , buyers are back |
Last chance to BUY below 40p |
 This is just in May. Give it a rest.
-----------------------------
Blackhorse23 - 14 May 2024 - 11:13:20 - 7289 of 7290 hVIVO plc - HVO
APH about to surge
Blackhorse23 - 14 May 2024 - 08:04:44 - 200 of 201 Light Science Technologies PLC: new vertical farming/agri-tech IPO - LST
Switched to APH
Blackhorse23 - 14 May 2024 - 08:04:19 - 639 of 647 Sondrel - SND
Money moved to APH
Blackhorse23 - 13 May 2024 - 10:14:08 - 24780 of 24801 ANGLE PLC - 2019 THREAD - LIQUID BIOPSY COMPANY - AGL
Money moved to APH ( alliance Pharma )
Blackhorse23 - 13 May 2024 - 10:12:29 - 9029 of 9040 British American Tobacco - BATS
Money moved to APH ( alliance Pharma )
Blackhorse23 - 13 May 2024 - 10:11:49 - 32933 of 32936 Glaxosmithkline - The recovery - GSK
Money moved to APH ( alliance Pharma )
Blackhorse23 - 13 May 2024 - 10:11:36 - 6031 of 6032 AstraZeneca - AZN
Money moved to APH ( alliance Pharma )
Blackhorse23 - 13 May 2024 - 10:11:07 - 13787 of 13802 Shield Therapeutics: poised for a US licensing deal - STX
Money moved to APH ( alliance Pharma )
Blackhorse23 - 13 May 2024 - 10:10:51 - 1610 of 1612 Respite for ARDS sufferers - FARN
Money moved to APH ( alliance Pharma )
Blackhorse23 - 10 May 2024 - 11:06:48 - 849 of 853 Plant Health Care; Using novel biological products in global markets - PHC
Money moved to APH
Blackhorse23 - 10 May 2024 - 11:06:23 - 3767 of 3830 Genedrive, A Game Changer for Point of Care Testing Market? - GDR
Money moved to APH
Blackhorse23 - 03 May 2024 - 10:55:15 - 7269 of 7290 hVIVO plc - HVO
Money moved to APH
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders
-DIVIDEND +5%
-PORTFOLIO BROADENED THROUGH ACQUISITION
Blackhorse23 - 03 May 2024 - 10:53:49 - 6023 of 6032 AstraZeneca - AZN
Money moving to APH
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders
-DIVIDEND +5%
-PORTFOLIO BROADENED THROUGH ACQUISITION
Blackhorse23 - 03 May 2024 - 10:52:38 - 21034 of 21134 FUTURA a winner for 2015 - FUM
Money moved to APH
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders
-DIVIDEND +5%
-PORTFOLIO BROADENED THROUGH ACQUISITION
Blackhorse23 - 03 May 2024 - 10:52:12 - 579 of 618 O B I - OBI
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders
-DIVIDEND +5%
-PORTFOLIO BROADENED THROUGH ACQUISITION
Blackhorse23 - 03 May 2024 - 10:51:35 - 3673 of 3830 Genedrive, A Game Changer for Point of Care Testing Market? - GDR
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders
-DIVIDEND +5%
-PORTFOLIO BROADENED THROUGH ACQUISITION
Blackhorse23 - 03 May 2024 - 10:50:53 - 7759 of 7889 OXB. One owner, FSH Excellent conditionwith ejector seat - OXB
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders
-DIVIDEND +5%
-PORTFOLIO BROADENED THROUGH ACQUISITION
Blackhorse23 - 03 May 2024 - 10:50:34 - 57646 of 57659 Avacta – Innovative and Disruptive Technologies for Global Health Markets - AVCT
AlliancePharma [APH] has an impressive record of long-term growth & creating sustainable value for our shareholders & stakeholders
-DIVIDEND +5%
-PORTFOLIO BROADENED THROUGH ACQUISITION
Blackhorse23 - 03 May 2024 - 10:49:35 - 57645 of 57659 Avacta – Innovative and Disruptive Technologies for Global Health Markets - AVCT
Yes mate , money moved to APH
Blackhorse23 - 02 May 2024 - 19:11:04 - 7744 of 7889 OXB. One owner, FSH Excellent conditionwith ejector seat - OXB
Some investors sold out here & bought APH ( alliance Pharma ) |
Potentially a minimum gain of circa 30% or more.
But WTFDWK blacky |
 Alliance Pharma plc (AIM: APH), the international healthcare group, announces its trading update for the year ended 31 December 2023 (the "Period"), ahead of the announcement of the Group's audited results in March 2024, which are anticipated to be in line with market expectations.Financial summaryThe Group delivered record see-through1 revenues in the Period of £182.7m (FY22: £172.0m), up 6% versus the prior period and up 7% at constant exchange rates ("CER"). Excluding sales from ScarAway and the US rights to Kelo-Cote in Q1 23, both acquired in March 2022 (the "US Acquisition"), like-for-like see-through revenues increased 6% CER. Continued strong consumer demand, particularly in China, drove significant recovery in Kelo-Cote franchise revenues in H2, leading to FY23 revenues of £63.2m, up 29% CER (FY22: £50.0m). Nizoral revenues increased 3% CER to £21.7m (FY22: £21.8m) whilst Amberen revenues declined 6% CER on an underlying basis (excluding the leading discount store account that was lost in 2022) and decreased 25% CER to £11.2m (FY22: £14.9m) on a reported basis. With Other Consumer brands up 5% CER to £40.3m (FY22: £38.4m), total see-through Consumer Healthcare revenues increased 11% CER to £136.4m. Prescription Medicine revenues were stable at £46.3m (FY22: £46.8m), reflecting a strong recovery in H2 as expected, as previously out of stock products became available. Underlying profit for the Period is anticipated to be in-line with market expectations. |
CURYman is here?... |
Get out while you can. Moneys moving anywhere but here!! |
Likely sudden dividend announcement |
CEO departs. Results delayed, and delayed again. I'm a holder, but certainly not the time to be topping saying everything is rosy. All we need now is for the shares to be suddenly suspended... |
If you are so confident this will rise, why do you continue to plaster the advfn site with claims you are selling other shares to buy here? |
expecting results: record see-through revenues of ?182.7m (FY22: ?172.0m)?~Continued strong consumer demand?~Free cash flow in the Period rose 34% to ?21.1m (FY22: ?15.8m)HSBC upgraded to BUY few weeks ago |
Buyers are back lol |
U still in bed lol |
Black rock have an open short here
Could go to zero so avoid for now, profits into AGL (Angle plc)
sent from my iPhone |
Sold APH bought AGL much better play
How's that Enquest short going horse boy
sent from my iPhone |
expecting results: record see-through revenues of £182.7m (FY22: £172.0m) ~Continued strong consumer demand ~Free cash flow in the Period rose 34% to £21.1m (FY22: £15.8m) |
Sold my lot here and bought AGL dip |
alliancepharma :-record revenues up 6% to £182.7m-FY24 profit guideline £50m-strong consumer demand -Free cash flow up 34% to £21.1m |
I've been bitten many times in the past by such hubris. All investment is a calculated risk. At the moment with Alliance the odds are stacked against you. |
That's tricky points, when pictures are clear share price will be skyrocketing values, everyone is waiting for that to buy same time. My point is I buy before anyone buy & sell before anyone sell. UPON TRADING UPDATE ON 29th JANUARY I AM HAPPY ENOUGH TO BUY & HOLD before anyone does. That's most of profit margin is |
The word you use is slowly. My point exactly. Fools rush in. Better to wait for more certainty. If things are all good then shares will recover. Slowly. I should add I'm a long suffering holder here but will only consider averaging down when the picture is clearer. |
Up 40% since the Tuesday lows: of course no one knows the future but the vast majority on this board got things very wrong indeed. |
You could double or halve your money next week ..play at your own risk. ;))) |
Register for real-time alerts, custom portfolio, and market movers
Hot Features
Premium
